These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 7274651
21. Decrease of cytotoxic immune lymphoid cells following regression of virus-induced sarcomas in mice. Levy JP, Lechlerc JC, Gomard E, Pavie J, Kourilsky F. Bibl Haematol; 1973; 39():689-97. PubMed ID: 4798253 [No Abstract] [Full Text] [Related]
28. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity. Epstein LB, Knight RA. Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852 [Abstract] [Full Text] [Related]
30. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D. J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589 [Abstract] [Full Text] [Related]
32. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC, Burakoff SJ, Faller DV. J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792 [Abstract] [Full Text] [Related]
33. The in vivo role of leukocyte function-associated antigen-1 in cytotoxic cell activity against tumors induced by Moloney-murine sarcoma/leukemia retroviral complex. Rosato A, Bronte V, Pollis F, Mandruzzato S, Zambon A, Zanovello P, Collavo D. Leukemia; 1992 Oct; 6 Suppl 3():166S-167S. PubMed ID: 1602816 [Abstract] [Full Text] [Related]
34. Mixed lymphocyte/tumor-cell interaction in a murine sarcoma virus (Moloney)-induced tumor system. Comparison between lymphoproliferation and lymphocyte cytotoxicity. Kirchner H, Glaser M, Holden HT, Herberman RB. Int J Cancer; 1976 Mar 15; 17(3):362-9. PubMed ID: 1254360 [Abstract] [Full Text] [Related]
36. [Functional activity of the lymphocytes of mouse lymph nodes in a system of viral carcinogenesis]. Umanskiĭ IuA, Evsev'eva AI, Semenova-Kobzar' RA, Kushko LIa. Tsitologiia; 1979 Feb 15; 21(2):191-5. PubMed ID: 432958 [Abstract] [Full Text] [Related]
37. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea. Einstein AB, Fass L, Fefer A. Cancer Res; 1975 Mar 15; 35(3):492-6. PubMed ID: 1078784 [Abstract] [Full Text] [Related]
38. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. McDonald TL. J Natl Cancer Inst; 1983 Mar 15; 70(3):493-7. PubMed ID: 6572738 [Abstract] [Full Text] [Related]
39. Secondary cytotoxic response in vitro against Moloney lymphoma cells antigenically altered by drug treatment in vivo. Santoni A, Kinney Y, Goldin A. J Natl Cancer Inst; 1978 Jan 15; 60(1):109-12. PubMed ID: 146746 [Abstract] [Full Text] [Related]
40. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma. Fass L, Fefer A. Cancer Res; 1972 Nov 15; 32(11):2427-31. PubMed ID: 5082591 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]